Minimal disease activity (MDA) was more likely in people with psoriatic arthritis (PsA) when they initiated a disease-modifying anti-rheumatic drug (DMARD) earlier rather than later. That's according ...
In their "Impact of delay of treatment with disease-modifying antirheumatic drugs (DMARDs) in psoriatic arthritis: The CorEvitas psoriatic arthritis/spondyloarthritis registry," published in ACR Open ...
Treatment with biologic DMARDs vs standard therapy improved clinical response rates and flare outcomes among patients with polyarticular JIA.
Biologic vs conventional DMARDs may offer cardioprotective benefits among patients with PsA, though an increased risk for infection requires vigilance.
SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost ...
SetPoint Medical, a company dedicated to developing therapies for people living with chronic autoimmune diseases, today ...
A phase 3 rheumatoid arthritis trial of Lynk Pharmaceuticals’ JAK1 inhibitor in China has hit its primary endpoint, boosting ...
SaveHealth reports on psoriatic arthritis medications, detailing options like DMARDs, biologics, and NSAIDs, including their ...
A national cohort study shows rheumatoid arthritis remission rates in England and Wales have plateaued since 2018, with wide ...
Objective Sjögren’s is a chronic systemic autoimmune disease characterised by dryness symptoms (eyes, mouth, skin), alongside ...
President Donald Trump said that the United States is going to "run" Venezuela until "we can do a safe, proper, and judicious transition." ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback